Working… Menu

Calcium Silicate Versus Calcium Hydroxide in Two-step Indirect Pulp Treatment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03032978
Recruitment Status : Completed
First Posted : January 26, 2017
Last Update Posted : January 27, 2020
Information provided by (Responsible Party):
ehsan hossam, Cairo University

Brief Summary:
Clinical and microbiological evaluation of Calcium silicate versus Calcium hydroxide in two-step indirect pulp treatment: Randomized clinical trial

Condition or disease Intervention/treatment Phase
Deep Caries Other: Calcium hydroxide Other: Calcium silicate Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 50 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Care Provider, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Clinical and Microbiological Evaluation of Calcium Silicate Versus Calcium Hydroxide in Two-step Indirect Pulp Treatment: Randomized Clinical Trial
Actual Study Start Date : April 20, 2018
Actual Primary Completion Date : March 1, 2019
Actual Study Completion Date : May 15, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Calcium

Arm Intervention/treatment
Experimental: Calcium silicate
Other: Calcium silicate
Pulp capping material
Other Name: Theracal

Active Comparator: Calcium Hydroxide
Other: Calcium hydroxide
Pulp capping material
Other Name: Dycal

Primary Outcome Measures :
  1. Pain: VAS [ Time Frame: 6 month ]
    post operative pain after 6 month from material application will be measured by visual analogue scale (VAS)with score from 0 to 10 in which 0 means no pain and 10 means the worst pain

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years to 50 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • 18-50 years.
  • Males or females.
  • Co-operative patients approving to participate in the trial.

Exclusion Criteria:

  • Patients younger than 19 years old or older than 50 years old.
  • Disabilities.
  • Systemic diseases or severe medically compromised.
  • Lack of compliance.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT03032978

Layout table for location information
Ehsan Hossam
Cairo, Giza Governorate, Egypt, 12345
Sponsors and Collaborators
Cairo University
Layout table for additonal information
Responsible Party: ehsan hossam, Assistant lecturer conservative dentistry - Ahram canadian university, Cairo University Identifier: NCT03032978    
Other Study ID Numbers: CEBD-CU-2017-01-06
First Posted: January 26, 2017    Key Record Dates
Last Update Posted: January 27, 2020
Last Verified: January 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Product Manufactured in and Exported from the U.S.: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Calcium, Dietary
Calcium-Regulating Hormones and Agents
Physiological Effects of Drugs
Bone Density Conservation Agents